Advertisement

Liposome Targeting to Tumor Cells in Vivo

  • D. Papahadjopoulos
  • A. Gabizon
Part of the NATO ASI Series book series (NSSA, volume 199)

Abstract

Considerable effort has been mounted both in our own and other laboratories in order to enhance the ability of liposomes to deliver drugs to specific cells. This effort resulted in the development of methods for conjugation of antibodies on the liposome surface (Heath et al, 1980; Leserman et al, 1980; Huang et al, 1980), temperature-sensitive liposomes (Papahadjopoulos et al, 1973; Yatvin et al, 1978) which can be used in conjunction with hyperthermia (Weinstein et al, 1979) and pH-sensitive liposomes, either for localization of drugs in low pH areas (Yatvin et al, 1980) or for release of the liposome-encapsulated drugs following endocytosis (Dusgunes et al, 1985; Ellens et al, 1984; Connor et al, 1984).

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Allen, T.M., 1981, A study of phospholipid interactions between high density lipoproteins and small unilamellar vesicles, Biochim.Biophys.Acta, 640:385.CrossRefGoogle Scholar
  2. Allen, T.M. and Chonn, A., 1987, Large unilamellar liposomes with low uptake into the reticuloendothelial system, FEBS Lett., 223:42.CrossRefGoogle Scholar
  3. Allen, T.M., Ryan, J.L. and Papahadjopoulos, D., 1985, Gangliosides reduce leakage of aqueous-space markers from liposomes in the presence of plasma, Biochim.Biophys.Acta, 818:205.CrossRefGoogle Scholar
  4. Connor, J., Yatvin, M.B. and Hiang, L., 1984, pH-sensitive liposomes: Acid- induced liposome fusion, Proc.Natl.Acad.Sci.USA, 81:1715.CrossRefGoogle Scholar
  5. Davies, A.J.S. and Crumpton, M.J., eds. 1982, in: “Experimental Approaches to Drug Targeting”, Cancer Surveys 1(3):347.Google Scholar
  6. Davis, S.S. and Hum, L., 1986, Colloidal delivery systems: opportunities and challenges, in: “Site-Specific Drug Delivery”, E. Tomlinson and S.S. Davis, eds., J. Wiley and Sons.Google Scholar
  7. Duzgunes, N., Straubinger, R.M., Baldwin, P.A., Friend, D.S. and Papahadjopoulos, D., 1984, Proton-induced fusion of oleic acid/ phosphatidylethanolamine liposomes, Biochistry, 24:3091.CrossRefGoogle Scholar
  8. Ellens, H., Bentz, J. and Szoka, F., 1984, H+ and Ca2+-induced fusion and destabilization of liposanes. Biochemistry, 23:1532.CrossRefGoogle Scholar
  9. Gabizon, A. and Trainin, N., 1980, Enhancement of growth of a radiotion- induced lymphoma by T cells from normal mice, Br.J.Cancer, 42:551.CrossRefGoogle Scholar
  10. Gabizon, A. and Papahadjopoulos, D., 1988, Liposome formulations with prolonged circiiLation time in blood and enhanced uptake by tumors, Proc.Natl.Acad.Sci., 85:6949.CrossRefGoogle Scholar
  11. Gabizon, A., Huberty, J., Straubinger, R.M., Price, D.C. and Papahadjopoulos D., 1988, An improved method for in vivo tracing and imaging of liposcanes using a gallium-67-deferoxamine complex, J. Liposome Res., 1:124.CrossRefGoogle Scholar
  12. Gabizon, A., Shiota, R. and Papahadjopoulos, D., 1989, Pharmacokinetics and tissue distribution of doxorubicin encapsulated in stable liposomes with long circulation times, J.Nat.Cancer Inst., 81:1485.CrossRefGoogle Scholar
  13. Gregoriadis, G. and Senior, J., 1986, Liposomes in vivo: a relationship between stability and clearance, to: “Targeting of Drugs with Synthetic Systems”, G. Gregoriadis, J. Senior and G. Poste, eds.. Plenum Press, New York.CrossRefGoogle Scholar
  14. Heath, T.D., Fraley, R. and Papahadjopoulos, D., 1980, Antibody targeting of liposomes. Science, 210:539.CrossRefGoogle Scholar
  15. Heaton, W.A., Davis, H.H., Welch, M.J., Mathias, C.J., Joist, H.H., Sherman, L.A. and Siegel, B.A., Br.J.Haematol., 42:613.Google Scholar
  16. Hiang, A., Huang, L. and Kennel, S.J., 1980, Monoclonal antibody covalently coupled to fatty acids: a reagent for in vitro liposome targeting, J.Biol.Chem., 255:8015.Google Scholar
  17. Hwang, K.J., Luk, K.K. and Beaumier, P.L., 1980, Hepatic uptake and degradation of unilamellar sphingomyelin/cholesterol liposomes: a kinetic study, Proc.Natl.Acad. Sci.USA, 77:4030.CrossRefGoogle Scholar
  18. Jain, R.K. and Gerlowski, L.E., 1986, Extravascxilar transport in normal and tumor tissues, Crit.Rev.Oncol.Hematol., 5:115.CrossRefGoogle Scholar
  19. Leserman, L.D., Barbet, J., Kourilsky, F.M. and Weinstein, J.N., 1980, Targeting to cells of fluorescent liposomes covalently coupled with monoclonal antibody. Nature (London), 288:602.CrossRefGoogle Scholar
  20. Matthay, K.K., Abai, A., Cobb, S., Hong, K. and Papahadjopoulos, D., 1989, Role of ligand in antibody-directed endocytosis of liposomes by human T-leukemia cells. Cancer Res., 49:4879.PubMedGoogle Scholar
  21. Mayhew, E. and Papahadjopoiüos, D., 1983, Therapeutic applications of liposomes, to: “Liposomes”, M.J. Ostro, ed.. Marcel Dekker, New York, Inc.Google Scholar
  22. Mayhew, E., Rustum, Y., Szoka, F. and Papahadjopoiilos, D., 1979, Role of cholesterol in enhancing the antitumor activity of cytosine arabinoside entrapped in liposomes. Cancer Treat.Rep., 63:1923.PubMedGoogle Scholar
  23. Order, S., 1987, ed., in: “Labeled and Unlabeled Antibody in Cancer Diagnosis and Therapy”, NCI Monogr. 3.Google Scholar
  24. Papahadjopoulos, D. and Gabizon, A., 1987, Targeting of liposomes to tumor cells in vivo, Ann.NY Acad.Sci., 504:64.CrossRefGoogle Scholar
  25. Papahadjopoulos, D., Jacobson, K., Nir, S. and Isac, T., 1973, Phase transitions in phospholipid vesicles: fluorescence polarization and permeability properties concerning the effect of temperature and cholesterol, Biochim.Biophys.Acta, 311:330.CrossRefGoogle Scholar
  26. Poste, G., 1983, Liposome targeting in vivo: problems and opportunities, Biol.Cell, 47:19.Google Scholar
  27. Proffitt, R.T., Williams, L.E., Présant, C.A., Tin, G.W., Uliana, J.A., Gamble, R.C. and Balde schwieler, J.D., 1983, Liposomal blockage of the reticulendothelial system: improved tumor imaging with small unilamellar vesicles, Science, 220:502.CrossRefGoogle Scholar
  28. Senior, J.H., 1987, Fate and behaviour of liposomes in vivo: a review of controlling factors, CRC Crit.Rev.Ther.Drug Carrier Systems, 3:123.Google Scholar
  29. Senior, J. and Gregoriadis, G., 1982, Stability of small unilamellar liposomes in serum and clearance fron the circulation: effect of phospholipid and cholesterol components, Life Sci., 30:2123.CrossRefGoogle Scholar
  30. Straubinger, R.M., Lopez, N.G., Debs, R.J. and Papahadjopoulos, D., 1988, Liposome-based therapy of human ovarian cancer: liposcxne-cell interaction control potency of negatively-charged and antibody- targeted liposomes, Cancer Res., 48:5237.PubMedGoogle Scholar
  31. Weinstein, J.N., Magin, R.L., Yatvin, M.B. and Zaharko, D.S., 1979, Liposomes and local hyperthermia: selective delivery of methotrexate to heated tumors, Science, 204:188.CrossRefGoogle Scholar
  32. Yatvin, M.B., Weinstein, J.N., Dennis, W.H., 1978, Design of liposomes for enhanced local release of drugs by hyperthermia. Science, 202:1290.CrossRefGoogle Scholar
  33. Yatvin, M.B., Kreutz, W., Horwitz, B.A. and Shinitzky, M., 1980, PH- sensitive liposomes: possible clinical implications. Science, 210:1253.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1990

Authors and Affiliations

  • D. Papahadjopoulos
    • 1
  • A. Gabizon
    • 1
    • 2
  1. 1.Cancer Research Institute and Department of PharmacologyUniversity of CaliforniaSan FranciscoUSA
  2. 2.Liposome Technology, Inc.Menlo ParkUSA

Personalised recommendations